Using a more pragmatic classification system than the current standard provided clearer discrimination between disease ...

The management of cutaneous squamous cell carcinoma (CSCC) is undergoing a notable shift, with systemic immunotherapy playing ...

Multidisciplinary care is a cornerstone of modern management for high- and very-high-risk cutaneous squamous cell carcinoma ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced the latest research on the company's precision molecular diagnostics advances, including a new ...

A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study published online ...

Imaging is more sensitive than physical examination for nodal staging of cutaneous squamous cell carcinoma, according to a ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, arising from abnormal proliferation of epidermal keratinocytes due to chronic UV exposure. While highly curable (>90%) ...

Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more ...

Switching to sirolimus significantly reduces the risk of subsequent cSCC in high-risk kidney transplant recipients with history of the skin cancer. Switching kidney transplant recipients (KTRs) with ...